SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
SUI Group Holdings entered into an Amended and Restated Digital Asset Loan Agreement on June 19, 2026, whereby it will loan an additional 4,000,000 SUI tokens to BlueFin (totaling 6,000,000 SUI tokens), with BlueFin paying an 11% revenue share fee through September 2028. This material capital deployment and financial obligation creates a direct financial relationship with defined terms and recurring revenue participation.
View raw filing on EDGAR →Southern Copper Corporation completed a registered public offering of $1.25 billion in 5.350% unsecured notes due 2036, with net proceeds of approximately $1.24 billion. The proceeds will be used for the Tia Maria project development, capital expenditures, and general corporate purposes.
View raw filing on EDGAR →The Compensation Committee approved material changes to CFO John North's compensation package, including: (i) a base salary increase from $175,000 to $275,000 effective October 1, 2026; (ii) confirmation of a 100% annual target bonus opportunity; and (iii) modification of a market condition performance-vesting RSU arrangement with potential grants totaling up to $19.1 million ($1.6M + $7M + $10.5M) upon achievement of specified market capitalization, stock price, or EBITDA thresholds, plus additional change-of-control provisions. This is a classic executive compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →ON Semiconductor entered into a definitive Agreement and Plan of Reorganization to acquire Synaptics Incorporated in an all-stock transaction valued at approximately $7 billion, with an exchange ratio of 1.350 onsemi shares per Synaptics share, with expected closing in mid-2027.
View raw filing on EDGAR →BlackRock Private Credit Fund completed an unregistered private placement of 183,697.592 Institutional Class Shares for $4,345,329.81 to feeder vehicles, exempt under Section 4(a)(2) and Regulation S. This represents a significant capital raise and dilution to existing shareholders.
View raw filing on EDGAR →BlackRock Private Credit Fund declared regular distributions to shareholders across three share classes (Institutional, Class S, and Class D) with a gross per-share amount of $0.1784 (varying net amounts by class), record date of June 29, 2026, and payment date of July 29, 2026.
View raw filing on EDGAR →Synaptics entered into a definitive Agreement and Plan of Reorganization with ON Semiconductor Corporation for an all-stock merger transaction valued at approximately $7 billion, with a fixed exchange ratio of 1.350 shares of onsemi common stock per Synaptics share. Synaptics will survive as an indirect wholly-owned subsidiary of onsemi, subject to stockholder approval and regulatory clearance, with expected closing in mid-2027.
View raw filing on EDGAR →This is a clear earnings release for Acuity Inc.'s fiscal 2026 third-quarter results (quarter ended May 31, 2026), issued on June 25, 2026. The press release discloses net sales of $1.2B (up 2% YoY), operating profit of $193M (up 38% YoY), and diluted EPS of $4.56 (up 46% YoY), along with detailed segment performance and cash flow metrics. The filing explicitly states the press release is attached as Exhibit 99.1 and incorporated by reference under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.
View raw filing on EDGAR →Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. Mazelsky brings significant executive experience, including 14 years at IDEXX Laboratories where he served as President and CEO, and prior leadership roles at Philips and Agilent.
View raw filing on EDGAR →Constellation announced an extension of exchange offers for approximately $2.3 billion in unregistered notes originally issued in January 2026, now being exchanged for registered notes with identical terms. While technically an exchange rather than a new issuance, this disclosure involves the creation and management of a material direct financial obligation ($2.3 billion in aggregate principal). The event is material to investors as it affects the company's capital structure and debt obligations, though the core financial obligation itself was created in January 2026; this filing documents the extension of the registration/exchange process for those obligations.
View raw filing on EDGAR →This press release discloses results of a comprehensive geophysical survey program at the Corani Silver Project, including airborne magnetic surveys and induced polarization-resistivity surveys totaling over 90 km and 600 km respectively. The disclosure identifies multiple high-priority exploration targets (Corani West, Corani East Extension, Corani South) with geophysical signatures consistent with the Corani deposit, and announces the commencement of a first exploration drilling program in over a decade with four drill rigs active and first assays expected in July. This is a material operational/exploration milestone for a mining company, affecting investor assessment of the project's scale and development trajectory, but does not fit the discrete event categories (M&A, earnings, executive changes, etc.) and is therefore best classified as an operational event.
View raw filing on EDGAR →This press release discloses multiple operational and strategic milestones for a uranium-vanadium development company: completion of Phase One construction at Velvet-Wood with production targeted for end-2026, installation of monitoring wells at Shootaring Canyon Mill, acquisition of BRS Engineering, equipment procurement, and an updated PEA showing strong economics (106% pre-tax IRR, US$606M NPV, 1.3-year payback). While the PEA itself is a technical/economic assessment rather than a discrete earnings event, the bundle of operational achievements, construction completion, and strategic acquisitions constitutes material operational progress toward production. The disclosure does not fit neatly into a single named category (not a results release, M&A completion, or workforce action), making `operational_other` the most appropriate classification for this multi-faceted operational and strategic update.
View raw filing on EDGAR →This press release announces Intermap's award of a third DOD research subcontract for GPS-denied navigation technology development. The disclosure describes a material operational and strategic milestone—a significant government contract win that expands the company's defense and aerospace portfolio and validates its geospatial intelligence capabilities. While not a discrete M&A transaction, earnings event, or executive change, it represents a material operational achievement that would affect a reasonable investor's assessment of the company's growth trajectory and market positioning in the defense sector.
View raw filing on EDGAR →This press release discloses the results of Cellectis' shareholders general meeting held on June 25, 2026, reporting that resolutions 1–29 were adopted and resolution 30 was rejected, with approximately 55.84% of voting rights exercised. This is a direct disclosure of shareholder vote results, matching Item 5.07 of the 8-K taxonomy and the `shareholder_vote_results` event type. The outcome of shareholder votes on board-recommended resolutions is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →The Board of Directors declared a cash dividend of $0.32 per share payable on September 3, 2026, to stockholders of record as of August 20, 2026. This is a routine quarterly dividend distribution, which is a material event affecting shareholders' returns and the company's capital allocation policy.
View raw filing on EDGAR →This press release announces Titan Mining's receipt of Conditional Selection Notices from the U.S. Army for Enhanced Use Lease opportunities to establish graphite purification facilities at two strategic defense installations (Pine Bluff Arsenal and Anniston Army Depot). The disclosure describes a landmark public-private partnership for critical minerals processing infrastructure, with a 50-year lease term, zero taxpayer cost, and construction targeted for H2 2027. While this is a significant strategic and operational milestone for the company's graphite business and domestic supply chain positioning, it does not fit the specific event categories of M&A activity (no acquisition/merger), debt issuance, or other named financial/governance events. It is clearly material to investors as it represents a major operational and strategic development affecting the company's growth trajectory and market positioning in critical minerals.
View raw filing on EDGAR →Equinox Gold announces execution of 20-year land access agreements with three communities hosting its Los Filos Mine in Mexico and initiation of planning for mine restart and expansion. This is a material operational and strategic milestone—securing long-term community agreements is a prerequisite for mine restart and production expansion at a world-class deposit containing 5.4 million ounces of proven and probable reserves. The announcement discloses commencement of heap leach restart activities and technical studies to evaluate CIL facility construction and production expansion, which are significant operational developments affecting the company's future production profile and value creation.
View raw filing on EDGAR →Americas CarMart has experienced or anticipates experiencing events of default under its Credit Agreement, including failure or expected failure to comply with financial covenants (minimum liquidity, Collateral Coverage Ratio) and reporting obligations. The company entered into a First Amendment and Limited Waiver with lenders, paying $18 million in fees to secure a waiver of these defaults for a specified period, though uncertainty remains about achieving a sustainable capital structure.
View raw filing on EDGAR →The company appointed Gilbert E. Nathan and Michael J. Wartell as independent directors and appointed Marie Persichetti as Chief Financial Officer effective August 1, 2026, replacing Jonathan Collins who resigned effective July 31, 2026. These appointments were made in accordance with the company's obligations under the Credit Agreement amendment and include detailed compensation and retention arrangements.
View raw filing on EDGAR →Enlight announces the financial close of a debt financing framework agreement for its CO Bar complex, securing construction financing commitments totaling $2,622 million from seven major financial institutions (Wells Fargo, BNP Paribas, Crédit Agricole, Natixis, Norddeutsche Landesbank, Societe Generale, and MUFG Bank). The disclosure details the debt structure, including conversion to term loans with 25-year amortization for solar and 20-year for storage, all-in interest rate of 5.9%, and parent guarantor obligations—all hallmarks of a material debt issuance event.
View raw filing on EDGAR →The 6-K discloses results of Silicom's Annual General Meeting of Shareholders held June 3, 2026, including approval of director re-election, executive salary increases, auditor appointment, and notably the rejection and subsequent override of RSU grants to the CEO and Chairman. The override of shareholder rejection of executive compensation and the conditional approval of RSUs tied to a $83 million revenue threshold are material governance and compensation events affecting investor assessment of executive incentives and board authority.
View raw filing on EDGAR →The exhibit discloses an update on withholding tax procedures in connection with a dividend distribution of $0.50 per ordinary share (approximately $10 million) expected to be paid on July 8, 2026, as previously announced on May 26, 2026. The document details the Israeli Tax Authority ruling on withholding tax rates and procedures for shareholders receiving this dividend, making it a material disclosure of a dividend distribution event.
View raw filing on EDGAR →The filing discloses the departure of Asaf Alperovitz as Chief Financial Officer, effective May 31, 2026, following his notification in March 2026. While the section also mentions a special cash bonus approved by the Compensation Committee, the principal disclosed action is the CFO's departure. The bonus is secondary and appears to be a severance/transition arrangement rather than a prospective compensation arrangement, making exec_departure the most salient classification.
View raw filing on EDGAR →This exhibit is a press release announcing expanded preclinical study results for PRF-110, the company's lead product candidate, showing comparable analgesic efficacy to an approved benchmark (ZYNRELEF) with favorable pharmacokinetic properties. While the disclosure is clearly operational and product-development focused, it does not fit the discrete event categories (no earnings release, M&A, executive change, or litigation). As a clinical-stage pharmaceutical company's announcement of material preclinical progress on its lead candidate, this is a significant operational milestone that would affect a reasonable investor's assessment of the company's development trajectory and commercial prospects.
View raw filing on EDGAR →InMode disclosed a patent infringement lawsuit filed by Serendia LLC on June 22, 2026, alleging infringement of four U.S. patents related to the Company's Morpheus8 microneedling devices. The complaint seeks unspecified damages and an injunction against importation and sale of the accused products, and a parallel ITC complaint seeks exclusion and cease-and-desist orders. This is material litigation that would affect a reasonable investor's assessment of the Company's ability to continue selling a key product line.
View raw filing on EDGAR →REalloys entered into a Securities Purchase Agreement on June 24, 2026, to issue approximately 7,017,540 shares of common stock in a private placement at $14.25 per share, generating approximately $100 million in gross proceeds. The unregistered shares are being sold to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b), with registration rights agreements and lock-up provisions for officers and directors.
View raw filing on EDGAR →The filing discloses termination of a material merger agreement between BPGC Acquisition Corp. and iRocket Technologies, Inc. dated July 22, 2025. iRocket terminated the Merger Agreement on April 14, 2026, pursuant to a contractual deadline provision (March 16, 2026), and subsequent reinstatement discussions failed. This is a material M&A event under Item 1.02 involving the termination of a definitive merger agreement that would have constituted a change of control.
View raw filing on EDGAR →EShallGo announced a registered direct offering of 454,968 Class A Ordinary Shares at $3.25 per share, raising approximately $1.479 million in gross proceeds. This is a registered equity issuance under a Form F-3 shelf registration statement, which dilutes existing shareholders. The offering is material to investors as it affects share count, ownership percentages, and the company's capital structure.
View raw filing on EDGAR →Z Squared Inc. entered into a binding Letter of Intent on June 18, 2026, to acquire a majority membership interest in Paradox Data LLC, a digital infrastructure company with next-generation data center development assets. The transaction involves issuance of $5 million in Series D Convertible Preferred Stock and represents a significant strategic expansion into AI infrastructure and data center development.
View raw filing on EDGAR →GigCapital8 has entered into a non-binding letter of intent with Quantisimo Corp. (a special purpose vehicle established by WISeKey and SEALSQ) to combine through a business combination, with an initial enterprise value of approximately $575 million and expectations to reach $2 billion through additional acquisitions. This is a material acquisition/change-of-control transaction that would result in a combined public company, requiring shareholder approval and regulatory clearance. The disclosure explicitly states the parties intend to execute definitive agreements and complete the transaction in Q1 2027.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Aeva Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for the election of Class II directors (Hrach Simonian and Stephen Zadesky) and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (FOR, AGAINST, WITHHOLD, ABSTAIN, and broker non-votes) for each proposal, which is the standard format for shareholder vote results disclosures.
View raw filing on EDGAR →This press release discloses the results of GigaMedia's Annual General Meeting held on 25 June 2026, presenting poll results for five resolutions including adoption of audited financial statements, approval of auditors, directors' remuneration, share allotment authority, and share purchase mandate. The detailed voting tallies and percentages for each resolution are the core content, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →The 6-K discloses the results of ORIX Corporation's 63rd Annual General Meeting of Shareholders held on June 23, 2026, including voting outcomes on three proposals: amendments to Articles of Incorporation (two proposals) and election of ten directors. The filing presents detailed voting tallies (approvals, disapprovals, abstentions, and approval rates) for each matter, which is the core content of a shareholder vote results disclosure. This is material because director elections and bylaw amendments affect governance and investor rights.
View raw filing on EDGAR →This exhibit is a press release announcing Trip.com Group's unaudited financial results for the first quarter of 2026, including total net revenues of RMB16.2 billion (up 17% YoY), net income of RMB2.5 billion, and forward guidance for Q2 2026 (3–8% YoY growth). The document contains consolidated balance sheets and statements of income, making it a discrete earnings announcement rather than a periodic financial report filing. Material to investors as it discloses quarterly operating performance and revised growth outlook.
View raw filing on EDGAR →Kymera announced completion of enrollment in the Phase 2b BROADEN2 trial of KT-621 for atopic dermatitis ahead of schedule, with topline data accelerated to year-end 2026 (six months earlier than prior guidance) and Phase 3 initiation planned for mid-2027. This material clinical development milestone affects investor assessment of the company's pipeline progress and regulatory trajectory.
View raw filing on EDGAR →Grayscale Solana Staking ETF reduced its annual Sponsor's Fee from 0.35% to 0.19% of aggregate Trust assets and Sponsor's Staking Fee from 23% to 7%, effective June 25, 2026, pursuant to Amendment No. 3 to the Trust Agreement. This material reduction in the fund's fee structure directly affects investor returns and the ETF's cost economics.
View raw filing on EDGAR →Pitney Bowes amended its Credit Agreement on June 23, 2026, to provide an additional $150 million of incremental Term Loan A tranche, which was used to fund the redemption of $347 million of 6.875% Senior Notes due 2027. The transaction reflects an improved credit profile with new lender participation and represents a material refinancing of the company's debt structure.
View raw filing on EDGAR →Surf Air Mobility entered into a Master Subscription Agreement with Wheels Up for its Enterprise BrokerOS software, with an initial two-year term worth $8.0 million and an optional one-year extension worth $4.2 million (total up to $12 million). This represents a material commercial contract, strategic partnership, and significant revenue opportunity that validates the Company's software product.
View raw filing on EDGAR →Range Capital Acquisition Corp. issued an unsecured promissory note in the principal amount of up to $540,000 to its sponsor on June 18, 2026, to fund trust account contributions for the SPAC's business combination efforts.
View raw filing on EDGAR →Shareholders approved an amendment to the Company's Articles of Association extending the deadline for completing a business combination to 27 months from the IPO closing (December 23, 2024), with 11,660,851 shares voting in favor and 1,974,523 against; 9,339,529 ordinary shares were subsequently redeemed at approximately $10.62 per share, resulting in approximately $99.5 million in redemptions.
View raw filing on EDGAR →Jaguar Health executed the First Amendment to its Manufacturing and Supply Agreement with Woodward Specialty LLC, clarifying inventory management and title transfer procedures during an operational transition period through December 31, 2026.
View raw filing on EDGAR →The Company exercised its right to convert Series O Convertible Preferred Stock into common stock at a conversion ratio of 3.209 shares per preferred share, resulting in a material dilutive issuance of common stock that increases outstanding share count and dilutes existing common shareholders.
View raw filing on EDGAR →The filing discloses a proposed merger of Noble Africa LLC (ASP Isotopes' subsidiary holding Renergen Limited) with a subsidiary of ENDRA Life Sciences, with Noble Africa as the surviving entity and the combined company planning to list on Nasdaq. This is a material acquisition/change of control transaction. The concurrent $50 million private placement financing is integral to the transaction structure. The disclosure explicitly states the merger agreement terms, expected ownership structure (ASP ~89%, ENDRA ~3%, other investors ~7%), and anticipated closing in Q3-Q4 2026.
View raw filing on EDGAR →Clearwater Analytics completed an $8.4 billion take-private acquisition by a Permira and Warburg Pincus-led investor group on June 25, 2026. Stockholders received $24.55 per share in cash, and the company became a wholly owned subsidiary of the acquirer, resulting in delisting from the NYSE.
View raw filing on EDGAR →Concurrent with the merger closing, Clearwater entered into a new Credit Agreement providing $2.7 billion in senior secured term loans, $500 million in delayed draw term loans, and $325 million in revolving credit, totaling $3.525 billion in new direct financial obligations.
View raw filing on EDGAR →Effective upon the merger's consummation, the company amended its certificate of incorporation and bylaws, and the board of directors was reconstituted with director departures and appointments reflecting the change of control.
View raw filing on EDGAR →This exhibit announces a significant commercial expansion: MEDIROM MOTHER Labs has received an additional order from the Japan Ground Self-Defense Force (JGSDF) 8th Division that "triples" the deployment scale of its REMONY® remote health monitoring system. The announcement emphasizes the JGSDF's positive evaluation of the system's capabilities for heatstroke prevention and continuous health monitoring in harsh training environments. This represents a material operational and commercial milestone—a substantial expansion of an existing customer relationship with a government entity—that would affect a reasonable investor's assessment of the company's market traction and revenue prospects, though it does not fit the narrower categories of M&A, debt, or other specific event types.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of the Company's 2026 Annual Meeting of Stockholders held on June 23, 2026, including voting outcomes for two proposals: (1) election of directors Alexander Duka and Gary Kovacs as Class I directors, and (2) ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026. The detailed vote tallies (For, Against, Withhold, Abstain, Broker Non-Votes) are the core disclosure required by Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →The filing discloses the appointment of Pratik Trivedi as President and CEO effective July 6, 2026, along with his appointment to the Board, which is the principal disclosed action. While the filing also covers Kieran O'Sullivan's transition to Executive Chairman (a departure from CEO), the substantive focus and forward-looking impact center on Trivedi's appointment to the top executive role, including detailed compensation terms ($675,000 base salary, $2.15M long-term incentive award, and change-in-control severance provisions). This is a material executive succession event affecting investor assessment of company leadership.
View raw filing on EDGAR →This exhibit is a corporate presentation (investor deck) dated June 2026 disclosing Oculis' clinical development pipeline, preclinical and Phase 2 trial data for Privosegtor (optic neuritis neuroprotective candidate) and Licaminlimab (dry eye disease program), upcoming registrational milestones (PIONEER-1, PIONEER-2, PIONEER-3 trials), and financial position (cash runway into 2H 2029). The disclosure focuses on operational and clinical progress—trial designs, efficacy/safety results, regulatory designations (FDA Breakthrough, EMA PRIME, SPA agreement)—rather than a discrete event like M&A, executive change, or financial restatement. It is material because it updates investors on the status and timing of key value-driving clinical milestones and the company's pipeline advancement, which would affect a reasonable investor's assessment of the registrant's prospects.
View raw filing on EDGAR →